CTP-6: Phase I started

Celltrion began a double-blind, international Phase I trial to evaluate paclitaxel plus 8 mg/kg CTP-6 or 8 mg/kg Herceptin in 130 patients. CTP-6 is a biosimilar version of Herceptin trastuzumab, whi...